Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.08 USD | +11.19% | +32.19% | -26.84% |
05-02 | CUREVAC : A missed opportunity | |
04-26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.84% | 620M | |
+24.72% | 48.09B | |
+46.90% | 40.62B | |
-3.28% | 40.43B | |
-6.20% | 28.36B | |
+9.40% | 24.89B | |
-20.44% | 19.01B | |
+28.60% | 12.09B | |
+0.52% | 11.88B | |
-1.23% | 11.8B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac N : Posts Wider Q1 Pre-Tax Loss, Revenue Rises